1
Clinical Trials associated with Stable glucagon(Albireo Pharma, Inc.)Pharmacokinetics and Pharmacodynamics of BIOD-961 vs. Glucagon for Injection (Eli Lilly) and GlucaGen® (Novo Nordisk) Administered by Subcutaneous and Intramuscular Injection in Normal, Healthy Volunteers
BIOD-961 is a dry powder formulation of glucagon intended for use in a device that mixes (reconstitutes) the powder with liquid to make it easier for users to treat patients with severe hypoglycemia. The purpose of this study is to evaluate how much BIOD-961 absorbs into the bloodstream, how much it raises glucose concentrations (the intended effect) and compare to two glucagon products already on the market.
100 Clinical Results associated with Stable glucagon(Albireo Pharma, Inc.)
100 Translational Medicine associated with Stable glucagon(Albireo Pharma, Inc.)
100 Patents (Medical) associated with Stable glucagon(Albireo Pharma, Inc.)
100 Deals associated with Stable glucagon(Albireo Pharma, Inc.)